Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT
Bone Marrow Transplantation, Published online: 15 March 2024; doi:10.1038/s41409-024-02269-4Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT
Source: Bone Marrow Transplantation - Category: Hematology Authors: Marie Robin Simona Iacobelli Linda Koster Jakob Passweg Daniele Avenoso Keith M. O. Wilson Urpu Salmenniemi Peter Dreger Peter von dem Borne John A. Snowden Stephen Robinson Maria Chiara Finazzi Thomas Schroeder Matthew Collin Matthias Eder Edouard Forcad Source Type: research
More News: Bone Marrow Transplant | Cancer & Oncology | Hematology | Stem Cell Therapy | Stem Cells | Study | Transplants